Valiant Laboratories cash flow

Latest FY26
Cash from operations
−₹10.4cr₹1.3 cr in FY25
Capital spending
₹34.2cr−70.0% on FY25
Free cash flow
−₹44.6cr−₹113 cr in FY25
Cash from financing
₹1.8cr−96.0% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
Adjustments to reconcile profit — non-cash items
—6.02.12.0
—1.80.20.1
—−1.10.90.0
—0.20.90.0
—−0.00.00.0
—0.00.00.0
Changes in working capital
—−41.46.03.0
—−21.4−27.242.8
—0.0−0.2−1.4
—1.20.00.0
—−16.2−18.0−12.9
—0.420.6−8.6
—53.314.8−21.4
—1.1−0.0−1.0
—0.50.00.0
—5.30.1−0.9
—0.10.00.0
—0.00.40.0
Cash from operating activities
24.50.8−1.5−0.8
—−10.20.41.7
—−9.4−1.20.9
—1.0−2.5−1.0
—−10.41.31.9
Cash from investing activities
—34.211445.9
—0.00.10.0
—26.10.03.6
—0.00.094.4
—0.023.40.0
—67.537.60.0
—7.3−52.8−144
Cash from financing activities
—10.90.0136
—0.045.216.7
—76.30.00.0
—1.80.20.1
—69.0−0.30.0
—1.844.7152
—−1.4−6.810.5
—−1.4−6.810.5
———11.7
Reference items
33.36.4−4.7−8.4
10.9%2.7%−3.5%−4.6%
−44.6−44.6−113−44.0
—−123−67.6—
−₹8.22−₹8.22−₹20.72−₹8.10
—3.19×−0.60×5.90×
—1.0−2.5−1.0
—1.80.20.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VALIANTLAB₹125.82

Valiant Laboratories Limited

· Pharma & Health
₹ CrorePeersALBERTDAVDHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹683 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.02.16.0—
+ Finance Costs0.10.21.8—
+ Fair Value (Gains) / Losses0.00.9-1.1—
+ Other Non-cash Items0.00.90.2—
+ Other — Cash Effects are Investing / Financing0.00.0-0.0—
+ Other Reconciling Items0.00.00.0—
Changes in Working Capital
+ Inventories3.06.0-41.4—
+ Trade Receivables — Current42.8-27.2-21.4—
+ Other Financial Assets — Current-1.4-0.20.0—
+ Other Financial Assets — Non-current0.00.01.2—
+ Other Current Assets-12.9-18.0-16.2—
+ Other Non-current Assets-8.620.60.4—
+ Trade Payables — Current-21.414.853.3—
+ Other Financial Liabilities — Current-1.0-0.01.1—
+ Other Financial Liabilities — Non-current0.00.00.5—
+ Other Current Liabilities-0.90.15.3—
+ Provisions — Current0.00.00.1—
+ Provisions — Non-current0.00.40.0—
Cash from Operating Activities
Profit Before Tax (per I/S)-0.8-1.50.824.5
+ Total Adjustments (incl. Working Capital)1.70.4-10.2—
Cash from Operations (pre-tax)0.9-1.2-9.4—
+ Income Taxes Paid-1.0-2.51.0—
Cash from Operating Activities1.91.3-10.4—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)45.9113.934.2—
+ Disp of Fixed Assets0.00.10.0—
+ Purchase of Investments (Equity / Debt)3.60.026.1—
+ Payments on Futures / Forwards / Options / Swaps94.40.00.0—
+ Receipts on Futures / Forwards / Options / Swaps0.023.40.0—
+ Other Inflows / (Outflows) — Investing0.037.667.5—
Cash from Investing Activities-143.9-52.87.3—
Cash from Financing Activities
+ Proceeds from Issue of Shares135.90.010.9—
+ Proceeds from Borrowings16.745.20.0—
+ Repayment of Borrowings0.00.076.3—
+ Interest Paid0.10.21.8—
+ Other Inflows / (Outflows) — Financing0.0-0.369.0—
Cash from Financing Activities152.444.71.8—
Net Changes in Cash (pre-FX)10.5-6.8-1.4—
Net Changes in Cash10.5-6.8-1.4—
Closing Cash11.7———
Reference Items
EBITDA-8.4-4.76.433.3
EBITDA Margin %-4.62-3.512.6910.87
Free Cash Flow (CFO − Capex)-44.0-112.5-44.6-44.6
Free Cash Flow to Equity—-67.6-122.7—
Free Cash Flow per Basic Share-8.10-20.72-8.22-8.22
Cash Flow to Net Income5.90-0.603.19—
Cash Paid for Taxes-1.0-2.51.0—
Cash Paid for Interest0.10.21.8—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.